• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Technology

This implantable drug delivery system is self-powered

March 24, 2023 By Sean Whooley

Shirley Ryan AbilityLab Northwestern self-powered drug delivery system LED light

Researchers at Shirley Ryan AbilityLab and Northwestern University developed technology that uses external light sources to trigger drug delivery. Yamin Zhang and Dr. Colin Franz of Shirley Ryan and John Rogers of Northwestern led the research team. They say their technology represents the first implantable drug delivery system triggered by external light sources. These light […]

Filed Under: Drug-Device Combinations, Featured, Implants, Pharmaceuticals, Research & Development, Technology Tagged With: Northwestern University

Access in parts of Canada expands for Dexcom G6 CGM

March 22, 2023 By Sean Whooley

Dexcom G6 in action

Dexcom (Nasdaq:DXCM) announced that all people with type 1 and type 2 diabetes in Manitoba, Canada, meet eligibility criteria for its G6 CGM. As of the company’s announcement, Manitoba is the only province in Canada that does not require an application for coverage preapproval. That means improved access for patients and a reduced workload for […]

Filed Under: Business/Financial News, Diabetes, Featured, Patient Monitoring, Technology Tagged With: Dexcom

Stevanato Group, Thermo Fisher to bring on-body drug delivery system to market

March 21, 2023 By Sean Whooley

Stevanato Group Thermo Fisher collaboration on-body drug delivery system (1)

Stevanato Group (NYSE:STVN) today announced a collaboration with Thermo Fisher Scientific (NYSE:TMO) on drug delivery technology. The partnership aims to bring a fully integrated, on-body delivery system platform for subcutaneous administration to market. Stevanato Group said in a news release that the planned device will be semi-reusable and provide micro-precision basal doses and full-content bolus […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Pharmaceuticals, Technology Tagged With: Stevanato Group, thermofisherscientific

Study backs Tandem Control-IQ artificial pancreas in young children

March 16, 2023 By Sean Whooley

Tandem Diabetes Care tslim_X2_Insulin_Pump_Front_View_Control-IQ_RGB

Tandem Diabetes Care (Nasdaq:TNDM) announced positive study data for its artificial pancreas using Control-IQ technology. The study demonstrated improved blood sugar control in children ages 2-6 with type 1 diabetes. It evaluated an artificial pancreas using the Tandem t:slim x2 insulin pump with Control-IQ technology. Results were published in the New England Journal of Medicine.  […]

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Pediatrics, Technology Tagged With: Tandem Diabetes Care

Stevanato Group, Recipharm partner on pre-filled syringes for inhaled therapeutics

March 16, 2023 By Sean Whooley

Stevanato Group Recipharm pre-filled syringe inhalation device

Stevanato Group (NYSE:STVN) today announced a collaboration with Recipharm to manufacture pre-fillable syringes for soft mist inhalers. Piombino Dese, Italy-based Stevanato Group plans to lend manufacturing experience to support production of the syringes. As part of the collaboration, it intends to provide and manufacture its Alba glass pre-fillable syringe. Stevanato Group will assemble Alba with […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Technology Tagged With: Recipharm, Stevanato Group

Senseonics projects more than 20% growth in 2023

March 15, 2023 By Sean Whooley

Marketing image Senseonics Eversense E3 Ascensia Diabetes Care

Senseonics (NYSE:SENS) shares ticked up after hours today on fourth-quarter results that beat the consensus forecast. Shares of SENS rose 1.7% at 96¢ apiece after the market closed. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — closed the day up 1.7%. The Germantown, Maryland-based long-term implantable CGM […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Patient Monitoring, Technology, Wall Street Beat Tagged With: Senseonics

Nemaura Medical to offer CGM-guided insulin dose titration care model

March 15, 2023 By Sean Whooley

Nemaura ProBeat glucose monitor

Nemaura Medical (Nasdaq:NMRD) announced today that it now includes insulin under its DuoPack commercial license agreement. Loughborough, UK-based Nemaura Medical entered into a commercial agreement in September 2021 with MySugarWatch DuoPack Limited (MSWDL). Under the agreement, Nemaura’s non-invasive, wearable skin patch sensors paired with prescription-only medicines for type 2 diabetes. This created the MySugarWatch-branded “DuoPack.” […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Nemaura Medical

Insulet to replace Silicon Valley Bank in the S&P 500

March 13, 2023 By Sean Whooley

Insulet logo

S&P Dow Jones Indices announced that Insulet (Nasdaq:PODD) is set to replace Silicon Valley Bank in the S&P 500 index. The change becomes effective prior to the opening of trading on Wednesday, March 15. It adds Insulet to the index tracking 500 large companies listed on stock exchanges in the U.S. Silicon Valley Bank’s deletion […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology, Wall Street Beat Tagged With: Insulet

Analysts receive update on Embecta insulin patch pump progress

March 7, 2023 By Sean Whooley

BD Diabetes Spinoff Embecta

BTIG analysts Marie Thibault and Sam Eiber met with Embecta (Nasdaq:EMBC) executives last week and received an update on the company’s current position. Thibault and Eiber met with Embecta CFO Jake Elguicze and Head of Investor Relations Pravesh Khandelwal. Among a series of updates, the BTIG report said Embecta expects a “transitional period” in the […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Patient Monitoring, Regulatory/Compliance, Technology Tagged With: embecta

Bigfoot Biomedical takes next steps for its holistic diabetes management platform

March 6, 2023 By Sean Whooley

Bigfoot Biomedical Bigfoot Unity Abbott

After executing a significant IP sale, Bigfoot Biomedical looks to double down on its diabetes management platform. Less than two years ago, Bigfoot Biomedical launched its Bigfoot Unity platform in some U.S. states. CEO Jeffrey Brewer last year called it a “transformational attempt” to simplify CGMs and the data they produce. It features a smart […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Patient Monitoring, Regulatory/Compliance, Technology Tagged With: Bigfoot Biomedical

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 61
  • Page 62
  • Page 63
  • Page 64
  • Page 65
  • Interim pages omitted …
  • Page 89
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS